TP53 and neuroblastoma: The distinct responses of NB cell lines to ACBI1 and AU-15330 treatment may arise from genetic differences among NB cell lines, for instance, p53 mutation occurs in BE(2)C but not IMR5 or IMR32 (as detailed in the Materials and Methods section).